Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research    » Alternative Medicine    » Beta Cells    » Cause    » Cells    » Children    » Complications    » Control    » Cure    » Diagnosis    » Drugs    » Elderly    » Genes    » Immune Cells    » Inhaled Insulin    » Insulin    » Islet Cells    » Neuropathy    » Obesity    » Oral Insulin    » Other Diseases    » Pets    » Pre-Diabetes    » Prevention    » Research    » Retinopathy    » Risk Factors    » Stem Cells    » Technology    » Testing    » Transplants    » Treatments    » Trials    » Type 1    » Type 2 Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Research

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

New Study Advances Treatments to Prevent Type 2 and Metabolic Syndrome Posted: Friday, June 02, 2006

Insulin uses two distinct mechanisms to control glucose and the metabolism of blood fats (lipids) in the liver. Failures in each of these networks can lead to serious health problems: the breakdown of glucose metabolism that can lead to type 2 diabetes, and the malfunction of lipid metabolism contributing to metabolic syndrome, which is a cluster of conditions that puts people at increased risk of heart disease, vascular disease and type 2 diabetes.

Lipid-lowering Therapy Prevents Coronary Events in Diabetics Posted: Friday, June 02, 2006

Lipid-lowering drug treatment significantly reduced the risk of major coronary events in patients with and without type 2 diabetes, and that patients with diabetes derived more benefit from lipid-lowering therapy as primary and secondary prevention.

Obesity Triples the Risk of Chronic Kidney Failure Posted: Friday, June 02, 2006

According to the results of a new study, obesity is an important and potentially preventable risk factor for chronic renal failure (CRF). A BMI of 25 or higher triples the risk of chronic kidney failure.

Women Who Don't Snooze Enough Gain Weight Posted: Friday, June 02, 2006

Women who slept five hours or less per night gained 1.14 kg (2.5 lb) more than women who got in at least seven hours each night. That's the finding of researchers from Case Western Reserve University in Cleveland from a 16-year study.

Oral Contraceptive Use Protects Against Coronary Disease Later in Life Posted: Friday, June 02, 2006

In postmenopausal women undergoing coronary angiography for suspected myocardial ischemia, past oral contraceptive use is tied to less atherosclerotic disease, according to a new study.

Metabolic Syndrome Independently Tied to Heart Failure Posted: Friday, June 02, 2006

Findings from a new study suggest that metabolic syndrome is a risk factor for the development of heart failure, independent of known risk factors for the condition, such as interim MI.

Ghrelin Involved in Development of Diabetes Posted: Tuesday, May 30, 2006

Ghrelin, a hormone long considered a key player in obesity, may instead take a major role in maintaining the balance between insulin and glucose and the development of diabetes.

Insulin Identified as Trigger that Causes Type 1 Diabetes Posted: Tuesday, May 30, 2006

Two teams of scientists identified the hormone insulin last week as the antigeny in triggering Type 1 diabetes.

New Test Measures Quantity of Active Beta Cells Posted: Tuesday, May 30, 2006

Researchers at Columbia University Medical Center have identified a reliable, non-invasive imaging method that can measure the quantity of insulin-producing pancreatic beta cells.

Bristol-Myers Squibb Discontinues Development of Pargluva Posted: Tuesday, May 30, 2006

Researchers at the Cleveland Clinic found that Pargluva could double the risk of death, heart attack or strokes in diabetics compared to a placebo.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.